Matches in Nanopublications for { ?s ?p "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP864574.RAbfbiyHuQOgi_JbvUMr42xTbU9aiRpKlNg8YgY5vXb4U130_assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864574.RAbfbiyHuQOgi_JbvUMr42xTbU9aiRpKlNg8YgY5vXb4U130_provenance.
- assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP301104.RAaUAaA3KEC-ObRC0dfNjcjcMB3vmk72Yn2XnKQSbIfB0130_assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301104.RAaUAaA3KEC-ObRC0dfNjcjcMB3vmk72Yn2XnKQSbIfB0130_provenance.
- NP680241.RAT0fgB2BKy-h77y26vIQHuuNdRUWX4cU7jctkY_lghI4130_assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680241.RAT0fgB2BKy-h77y26vIQHuuNdRUWX4cU7jctkY_lghI4130_provenance.
- NP773382.RAVeaaN4IDaNAwsxYbYHs6lFvJMEHis_PRe2hjIHEjbIE130_assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773382.RAVeaaN4IDaNAwsxYbYHs6lFvJMEHis_PRe2hjIHEjbIE130_provenance.
- NP773379.RAPh1Rzw0RcKcYEVRvxB2zfcTo5iOd-vSpNEU_6RoaHjE130_assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773379.RAPh1Rzw0RcKcYEVRvxB2zfcTo5iOd-vSpNEU_6RoaHjE130_provenance.
- NP773383.RAxk3rvFOVjLwt3eKr8MFNBEOrvrgeRn0WoHJ7Z5AR69Y130_assertion description "[Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773383.RAxk3rvFOVjLwt3eKr8MFNBEOrvrgeRn0WoHJ7Z5AR69Y130_provenance.